148 related articles for article (PubMed ID: 9409220)
1. Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.
George SJ; Johnson JL; Angelini GD; Jeremy JY
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2500-6. PubMed ID: 9409220
[TBL] [Abstract][Full Text] [Related]
2. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
Kranzhöfer A; Baker AH; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
[TBL] [Abstract][Full Text] [Related]
3. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein.
George SJ; Johnson JL; Angelini GD; Newby AC; Baker AH
Hum Gene Ther; 1998 Apr; 9(6):867-77. PubMed ID: 9581909
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.
Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ
J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.
Porter KE; Naik J; Turner NA; Dickinson T; Thompson MM; London NJ
J Vasc Surg; 2002 Jul; 36(1):150-7. PubMed ID: 12096273
[TBL] [Abstract][Full Text] [Related]
8. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
9. Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein.
Johnson JL; van Eys GJ; Angelini GD; George SJ
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1146-51. PubMed ID: 11451743
[TBL] [Abstract][Full Text] [Related]
10. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts.
Southgate KM; Mehta D; Izzat MB; Newby AC; Angelini GD
Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1640-9. PubMed ID: 10397681
[TBL] [Abstract][Full Text] [Related]
11. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein.
George SJ; Zaltsman AB; Newby AC
Cardiovasc Res; 1997 Feb; 33(2):447-59. PubMed ID: 9074710
[TBL] [Abstract][Full Text] [Related]
12. Pyrogallol abates VSMC migration via modulation of Caveolin-1, matrix metalloproteinase and intima hyperplasia in carotid ligation mouse.
Ma YD; Thiyagarajan V; Tsai MJ; Lue SI; Chia YC; Shyue SK; Weng CF
Environ Toxicol Pharmacol; 2016 Dec; 48():63-75. PubMed ID: 27768988
[TBL] [Abstract][Full Text] [Related]
13. Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development.
Wang H; Liu C; Song Y; Gordon D; Alavi MZ; Moore S
Int J Mol Med; 2001 Jan; 7(1):105-12. PubMed ID: 11115618
[TBL] [Abstract][Full Text] [Related]
14. MMP inhibition reduces intimal hyperplasia in a human vein graft stenosis model.
Loftus IM; Porter K; Peterson M; Boyle J; London NJ; Bell PR; Thompson MM
Ann N Y Acad Sci; 1999 Jun; 878():547-50. PubMed ID: 10415769
[No Abstract] [Full Text] [Related]
15. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
[TBL] [Abstract][Full Text] [Related]
16. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair.
Meng X; Mavromatis K; Galis ZS
Exp Mol Pathol; 1999 Aug; 66(3):227-37. PubMed ID: 10486241
[TBL] [Abstract][Full Text] [Related]
17. Short-term exposure to low concentrations of thapsigargin inhibits replication of cultured human vascular smooth muscle cells.
Shukla N; Jeremy JY; Nicholl P; Krijgsman B; Stansby G; Hamilton G
Br J Surg; 1997 Mar; 84(3):325-30. PubMed ID: 9117297
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
19. Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture.
Patterson MA; Leville CD; Hower CD; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
J Surg Res; 2001 Jan; 95(1):67-72. PubMed ID: 11120638
[TBL] [Abstract][Full Text] [Related]
20. Potential role of vacuolar H-adenosine triphosphatase in neointimal formation in cultured human saphenous vein.
Otani H; Ohmiya H; Hattori R; Fujii H; Ninomiya H; Kido M; Kawaguchi H; Osako M; Imamura H; Ohta T; Ohkuma S
J Thorac Cardiovasc Surg; 2000 May; 119(5):998-1007. PubMed ID: 10788821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
